Fantastic session at @ctosociety! 🔬 A truly global debate on high-risk UPS: neoadjuvant RT vs surgery, RT+CTx, and RT+IO — with striking differences in viewpoints shaped by geography and therapeutic availability. 🌍💬 @alegronchi @DAmbrosio_MD

@apdeitos giving the Herman Suit's lecture at #CTOS2025. So we'll deserved 😊 Sarcoma diagnosis and it's Unexpected Journey

@ctosociety @WTapMD @herbloong @saxotomy @JohnEMullinaxMD @CrisyRoland @emilykeungMD @RobinL_Jones @DAmbrosio_MD @sandrapdangelo @sandro_pasquali It was a great start of the morning. Thank you to the mentors and experts for joining and sharing their insights and expertise. Most importantly thank you for the young colleagues for attending, engaging and ask challenging and important questions.

https://t.co/0i4BAIOiCk

Deepest condolences to his family. May his memory be a blessing and an inspiration for the next generations and for us all.

Preoperative therapy in high-risk UPS continues to challenge and inspire debate. Join the experts for a deep dive into balancing radiation and systemic therapy in modern sarcoma care. 📅 Thursday, Nov 13, 2025 ⏱️ 3:00–3:45 PM EST Engage! Debate! Redefine the standard! #CTOS2025

🚀 PUSHing Ultra-Rare Sarcomas Beyond Hope! Join the Ultra-Rare Sarcoma WG at #CTOS2025 (Nov 12, 1–3PM EST) for new insights on the PUSH Platform, PROSPER framework, and translational projects on P-/S-RMS, PEComa & histiocytic sarcoma. #CTOS2025 #UltraRareSarcoma #PUSH #Sarcoma

#CTOS2025 is not only about great science, it's also a perfect opportunity for mentorship for trainees and young fellows! Don't miss the 🌅 Sunrise Mentorship Session on Nov 13, 7.00 am ( breakfast and coffee will be served ☕)! Check topics and mentors 🧑‍🏫on the graphic⬇️

📢The @ItaSarcomaGroup consensus paper on extended molecular profiling 🧬in mesenchymal tumors is out‼️ Huge thanks to everyone who contributed to this collaborative effort! @SilviaStacchia @merlini_ale @sbamarta @apdeitos @MartinaRab95 https://t.co/09v5HAKr56

Hot off the press: 'How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancer' - our new paper on tackling drug development in ultra-rare sarcomas. https://t.co/kxTxWPH1TB

This National Cancer Research Month, we recognize the work of Dr. Lorenzo D'Ambrosio at the Università di Torino. Your support is crucial to our ability to identify and support groundbreaking research. Please help us maintain the momentum in EHE research. https://t.co/hcAfya2sIT

🚀 The @ItaSarcomaGroup Annual Meeting kicks off in beautiful #Florence! @SilviaStacchia leading a multidisciplinary, tight-knit community driving progress in #sarcoma care. #liposarcoma #leiomyosarcoma #osteosarcoma

Dr. @alegronchi 's talk at #esmorarecancers25 focused on shaping the next generation of neoadjuvant trials for high-risk sarcoma. Among the strategies: integrating chemotherapy with immunotherapy. The field is ready—are the trials? #Sarcoma #RareCancers

There is global momentum in #EHE research and advocacy! We were honored to work with @ehe_uk and @EheItalia to amplify patients' voices in shaping global research priorities and collaborating with the European Medicines Agency (EMA). #epithelioidhemangioendothelioma #EHEresearch

Some surprising Brightline-1 figures: only 1 STS subtype included; incidence only 1/330.000/year; only inoperable or metastatic 1st line patients eligible; trial open for accrual for only 752 days ….but: 455 patients screened and 400 patients randomized. YES WE CAN, SARCOMA!

#PUSH Pushing Ultra-rare Sarcomas towards Hope!

Great #CTOS 2024 Annual Meeting in San Diego! Always a unique time for ideas exchange and meeting new and old friends from all around the world. Looking forward for future steps in #sarcoma research! #PUSH @merlini_ale @SilviaStacchia @WTapMD @saxotomy @herbloong @alegronchi

CTOS2024 - it’s a wrap!! Thank you @ctosociety and @JasonSicklick for an inspiring, outstanding meeting! @DAmbrosio_MD @priyachudasama5 @SilviaStacchia @EHEfoundation

Interesting proposal for new response evaluation criteria in epithelioid hemangioendothelioma presented by Andrea Vanzulli from @IstTumori #CTOS2024 @ctosociety #CTOSTweeTOS #EHE @EHEfoundation

Da 'Gang' at da Gala @USSMidwayMuseum ! Thanks @JasonSicklick & @ctosociety for the epic party!🎉🥂 @HuangLabICR @sandro_pasquali @saxotomy @merlini_ale @DAmbrosio_MD